Pain

Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in term...

Biosimilars - news, reports, views and blogs

Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusi...

CaptureSelect

BAC’s CaptureSelect products are affinity ligands and affinity resins created by a proprietary technology based on Camelid-derived single domain antibody fragments for the purification of biop...

Blood - news, views, reports and blogs

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those...

Advair Diskus

Advair Diskus, a respiratory medicine produced by GSK, netted $3.6m in sales in 2009, making it the fourth most successfull drug (in terms of annual sales).   Advair is used in the treatment...

Bioniche: Graeme McRae on Bioniche`s Newly Discovered Cancer Killing Bacteria

In this episode of PharmaTelevision News Review, Fintan Walton talks with Graeme McRae, CEO at Bioniche. Filmed at BioChicago 2010 in Chicago, USA, they discuss: • Origins and focus of Bioniche •...

Bioniche Life Sciences Inc. Responds to Dissident Request for Shareholder Meeting

BELLEVILLE, ON, May 4, 2013 /PRNewswire/ - The Board of Directors of Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC) ("Bioniche" or the "Company"), on recommendation of a newly struck special co...

Bioniche Life Sciences Inc. Announces Discontinuation of Current Phase III Clinical Trial with Urocidin

-Bioniche and Endo discussing potential next steps for Urocidin™ clinical program- BELLEVILLE, ON, Nov. 5, 2012 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, techn...

Endo Pharmaceuticals Returns Urocidin Global Rights to Bioniche Life Sciences Inc.

Bioniche identifies potential for early access to the Canadian market

Bioniche Life Sciences Inc. Announces Discontinuation of Current Phase III Clinical Trial with ...

Bioniche and Endo discussing potential next steps for Urocidin™ clinical program

U.S. Distributor Appointed for Bioniche's Immunocidin(TM) Canine Oncology Therapy

- Vedco, Inc. of St. Joseph, Missouri selected as U.S. distributor - BELLEVILLE, ON, Nov. 21, 2012 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-dr...

Bioniche Life Sciences Inc. Responds to Letter from Former Biovail Executives

BELLEVILLE, ON, April 22, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today responded to a publis...

Bioniche Life Sciences Inc. Acknowledges Request for Shareholder Meeting

BELLEVILLE, ON, April 26, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today acknowledged that a sh...

Inappropriate and confusing electrocardiographic terms j-wave syndromes and early repolarization.

A plea is made for not using in publications the terms J-wave syndromes and early repolarization until such terms are properly defined by appropriate task forces established by recognized authorities....

First live offspring born in superovulated sika deer (Cervus nippon) after embryo vitrification.

The rapid growth in sika deer (Cervus nippon) farming and interest in their conservation is an impetus for development of embryo transfer (ET) procedures. However, a paucity of research has prevented...

Quantitative Analysis of Verbal Expressions in Comments From Evaluation Committee Reviewers in AIST Between Fiscal Years 2001 and 2008.

This article discusses the quantitative analysis of verbal expressions of comments from the evaluation committee reviewers for 8 years (FY2001-FY2008) at the Japanese Public Research Institute, Nation...

Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: bioequivalence of a new generic product with the branded product in healthy volunteers.

Abstract Objective: Parenteral sodium ferric gluconate in complex (Ferrlecit [branded SFG]) is used to treat patients with iron deficiency anemia undergoing chronic hemodialysis and receiving suppleme...

Terms used in patient safety related to medication: a literature review.

PURPOSE: There is a lack of homogeneity in the terminology used in the context of patient safety related to medication. The aim of this review was to identify the terms and definitions used in patient...